All In Biotech

Drug Trial Radar · NCT03511846

Pain Biomarker Study

The Pain Biomarker Study: Changes in Circulating Pain Signalling Molecules With Activation of Pain Receptors

Last checked: Nov 20, 2026Latest source record: Feb 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

371

Planned (sponsor's estimate)

Start

Mar 21, 2018

Primary completion

May 31, 2028

Study completion May 31, 2028

Sponsor

Lead sponsor
The University of Texas Health Science Center, HoustonAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of California, San Francisco
First posted
Apr 30, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study investigates molecular and physical biomarkers of headaches in order to better understand mechanisms of these diseases. There are 3 main parts: 1. Use of capsaicin (active ingredient in hot chili peppers) to trigger release of calcitonin gene related peptide - the hypothesis is that this will be different in headache subjects compared to controls (and if so might be used to predict how these patients will respond to certain medications that modulate calcitonin gene-related peptide). Subjects will be given capsaicin as a cream applied to the forehead or the inner nostril, or a hot sauce that is ingested. 2. Use of capsaicin to trigger eye watering - the hypothesis is that oxygen gas will slow down the amount of eye watering. Cluster headache patients respond very powerfully to oxygen gas but to very little else. The mechanism for oxygen is unknown but in rodents there is data that it works on the parasympathetic / lacrimal gland system. This study translates rodent data into humans in a non-invasive way to confirm the mechanism of this very effective treatment. 3. Use of ice water to trigger headaches - brain freeze causes a very short-lived but intense headache that may cause similar biomarker release as other headache disorders. This may be a useful human model for other headache disorders.

Conditions

  • Migraine
  • Cluster Headache
  • Trigeminal Autonomic Cephalgia
  • Hemicrania Continua
  • Paroxysmal Hemicrania
  • SUNCT
  • Short-Lasting Unilateral Neuralgiform Headache With Conjunctival Injection and Tearing

Interventions

  • Oral capsaicinDrug

    Subjects will drink a solution with capsaicin

  • Topical capsaicinDrug

    Capsaicin cream will be applied to the skin of the forehead, cheek, or leg

  • Intranasal capsaicinDrug

    Capsaicin cream will be applied to the nostril

  • Cold Water IrrigationOther

    Subjects will be asked to drink up to 2000 ml of cold water or ice water (temperature 0-10 degrees Celsius) as fast as possible, either continuously or intermittently (i.e. 200-800 ml at a time)

  • Medical AirOther

    Subjects will be exposed to medical air

  • Low Flow OxygenDrug

    Subjects will be exposed to oxygen gas between 1-9 L/min

  • High Flow OxygenDrug

    Subjects will be exposed to oxygen gas between 10-25 L/min

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Activation of trigeminoautonomic reflex as assessed by change in Calcitonin gene-related peptide (CGRP) levels from before stimulation to after stimulation.Time frame: 10 minutes before pain stimulation and 10 minutes, 20 minutes, 30 minutes, 60 minutes, and 90 minutes after pain stimulation
  2. Activation of trigeminoautonomic reflex as assessed by tear fluid productionTime frame: 90 minutes after pain stimulation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The University of Texas Health Science Center at Houston

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.